As of 2024-12-15, the EV/EBITDA ratio of Sedana Medical AB (publ) (SEDANA.ST) is -46.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SEDANA.ST's latest enterprise value is 1,340.49 mil SEK. SEDANA.ST's TTM EBITDA according to its financial statements is -28.88 mil SEK. Dividing these 2 quantities gives us the above SEDANA.ST EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 0.7x - 1.1x | 0.9x |
| Forward P/E multiples | 10.8x - 15.3x | 13.0x |
| Fair Price | 2.00 - 10.72 | 5.71 |
| Upside | -87.3% - -31.7% | -63.7% |
| Date | EV/EBITDA |
| 2024-12-11 | -48.35 |
| 2024-12-10 | -45.04 |
| 2024-12-09 | -36.58 |
| 2024-12-06 | -35.48 |
| 2024-12-05 | -35.75 |
| 2024-12-04 | -36.17 |
| 2024-12-03 | -37.34 |
| 2024-12-02 | -37.82 |
| 2024-11-29 | -36.58 |
| 2024-11-28 | -35.55 |
| 2024-11-27 | -34.45 |
| 2024-11-26 | -33.07 |
| 2024-11-25 | -35.48 |
| 2024-11-22 | -33.55 |
| 2024-11-21 | -34.59 |
| 2024-11-20 | -33.90 |
| 2024-11-19 | -29.15 |
| 2024-11-18 | -29.22 |
| 2024-11-15 | -30.25 |
| 2024-11-14 | -31.21 |
| 2024-11-13 | -32.38 |
| 2024-11-12 | -33.69 |
| 2024-11-11 | -36.65 |
| 2024-11-08 | -37.06 |
| 2024-11-07 | -37.68 |
| 2024-11-06 | -34.86 |
| 2024-11-05 | -35.55 |
| 2024-11-04 | -31.97 |
| 2024-11-01 | -31.76 |
| 2024-10-31 | -32.66 |
| 2024-10-30 | -36.99 |
| 2024-10-29 | -40.23 |
| 2024-10-28 | -42.29 |
| 2024-10-25 | -43.80 |
| 2024-10-24 | -44.91 |
| 2024-10-23 | -68.09 |
| 2024-10-22 | -70.15 |
| 2024-10-21 | -70.33 |
| 2024-10-18 | -71.01 |
| 2024-10-17 | -71.53 |
| 2024-10-16 | -68.61 |
| 2024-10-15 | -69.12 |
| 2024-10-14 | -70.67 |
| 2024-10-11 | -70.67 |
| 2024-10-10 | -71.87 |
| 2024-10-09 | -74.80 |
| 2024-10-08 | -73.25 |
| 2024-10-07 | -70.50 |
| 2024-10-04 | -72.56 |
| 2024-10-03 | -68.61 |